SCHEMBL1573465

SCHEMBL1573465

[CH2]n1ccnc1C(C)c1cccc(C)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 5/20 0.41
ADRA2A P08913 4/20 0.41
ADRA2B P18089 4/20 0.41
ADRA1A P35348 3/20 0.41
ADRA1B P35368 3/20 0.41
ADRA1D P25100 2/20 0.41
KCNH2 Q12809 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
SLC6A2 P23975 1/20 0.40
HTR7 P34969 1/20 0.40
KMT2A Q03164 2/20 0.33
FLT1 P17948 1/20 0.32
CDK8 P49336 1/20 0.32
CDK9 P50750 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1574207 1.00 ADRA2C (0.41) ADRA2CADRA2AADRA2BADRA1AADRA1B
SCHEMBL1573551 1.00 ADRA2C (0.41) ADRA2CADRA2AADRA2BADRA1AADRA1B
SCHEMBL697764 0.83 KDM4E (0.44) ADRA2CADRA2AADRA2BADRA1AADRA1B
SCHEMBL698665 0.83 KDM4E (0.44) ADRA2CADRA2AADRA2BADRA1AADRA1B
SCHEMBL1573555 0.83 KDM4E (0.44) ADRA2CADRA2AADRA2BADRA1AADRA1B
SCHEMBL698523 0.81 ADRA2C (0.41) ADRA2CADRA2AADRA2BADRA1AADRA1B
SCHEMBL698574 0.80 KMT2A (0.50) ADRA2CADRA2AADRA2BADRA1AADRA1B
SCHEMBL698793 0.80 KMT2A (0.50) ADRA2CADRA2AADRA2BADRA1AADRA1B
SCHEMBL704577 0.77 ADRA2A (0.38) ADRA2CADRA2AADRA2BADRA1AADRA1B
SCHEMBL1573467 0.77 ADRA2A (0.38) ADRA2CADRA2AADRA2BADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1981853-B1 SUBSTITUTED IMIDAZOLES AND THEIR USE AS PESTICIDES PFIZER LTD (GB) 2011-04-13 EP claimed
US-7825149-B2 Substituted imidazoles PFIZER LIMITED (GB) 2010-11-02 US disclosed
US-20090312326-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2009-12-17 US disclosed
US-7592362-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-09-22 US disclosed
US-7547718-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-16 US disclosed
US-7544706-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-09 US disclosed
US-20080125473-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-29 US disclosed
US-20080119536-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-22 US disclosed
US-20070167506-A1 SUBSTITUTED IMIDAZOLES PFIZER INC. (US) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125473-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 ADRA2C 144/4885ADRA2A 456/4885ADRA2B 317/4885
US-20090312326-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 ADRA2C 144/4885ADRA2A 456/4885ADRA2B 317/4885
US-20070167506-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 ADRA2C 144/4885ADRA2A 456/4885ADRA2B 317/4885
US-20080119536-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 ADRA2C 144/4885ADRA2A 456/4885ADRA2B 317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.